Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.

Translational psychiatry - 24 Jan 2012

Devlin A M, Ngai Y F, Ronsley R, Panagiotopoulos C

Abstract excerpt

Second-generation antipsychotics (SGAs) are increasingly being used to treat children with a variety of psychiatric illnesses. Metabolic syndrome (MetS), a risk factor for cardiovascular disease, is a side-effect of SGA-treatment. We conducted a cross-sectional study and assessed the association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Methylenetetrahydrofolate Reductase (NADPH2)
Share to Reference Values
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Glucose

Share to Cholesterol, HDL

Share to Mental Disorders

Share to Metabolic Syndrome

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 22832733
DOI: 10.1038/tp.2011.68
PMCID: PMC3309538

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22832733-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.PMID 22832733Read ↗

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity Read ↗

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read ↗

Interaction between the Val158Met catechol-O-methyltransferase gene variant and second-generation antipsychotic treatment on blood pressure in children.Semantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.Semantic proximity Read ↗

Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.Semantic proximity Read ↗

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study.Semantic proximity Read ↗

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity Read ↗

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.Semantic proximity Read ↗

Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.Semantic proximity Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.